JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Subperiosteal midface lift: its role in static lower eyelid reconstruction after chronic facial nerve palsy.

Orbit 2011 June
PURPOSE: To describe the effect of subperiosteal midface lift on lower eyelid position of patients with chronic facial nerve palsy.

METHODS: In an observational prospective study nine patients underwent subperiosteal midface lift. Indications for surgery were lower eyelid paralytic retraction, lagophthalmos, ocular surface disruption, reactive tearing, midface ptosis, and facial asymmetry. Exclusion criteria were previous rehabilitative oculofacial surgery, and facial nerve palsy onset less than a year. Preoperative and postoperative assessment included evaluation of lower eyelid position, lagophthalmos, midfacial ptosis and facial asymmetry. Follow-up was at 1 week, 1 month, 3, and 12 months, postoperatively.

RESULTS: All patients referred improvement in their symptoms at 3 and 12 months, postoperatively: lower eyelid position (P=. 004), lagophthalmos (P=. 004), ocular surface symptoms, reactive tearing, and facial symmetry at rest.

CONCLUSIONS: Subperiosteal midface lift has an effective role in the static lower eyelid malposition correction after chronic facial nerve palsy.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app